RA Capital Management - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 256 filers reported holding MIRATI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.5%.

Quarter-by-quarter ownership
RA Capital Management ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$60,378,000
+8.0%
734,343
+92.7%
1.32%
+33.7%
Q4 2021$55,896,000
+346.3%
381,046
-42.0%
0.98%
+9.7%
Q1 2014$12,525,000
+14.7%
656,7670.0%0.90%
-29.4%
Q4 2013$10,922,000
+30.7%
656,767
+19.0%
1.27%
+45.9%
Q3 2013$8,359,000551,7230.87%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders